Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,709
Closed -$20.2K 1851
2023
Q1
$20.2K Sell
2,709
-399
-13% -$3.99K ﹤0.01% 1736
2022
Q4
$38.5K Buy
3,108
+284
+10% +$4.98K ﹤0.01% 1763
2022
Q3
$58K Buy
2,824
+64
+2% +$1.78K ﹤0.01% 1649
2022
Q2
$76K Sell
2,760
-656
-19% -$22.5K ﹤0.01% 1650
2022
Q1
$149K Sell
3,416
-807
-19% -$35.1K ﹤0.01% 1954
2021
Q4
$232K Buy
4,223
+194
+5% +$12K ﹤0.01% 1938
2021
Q3
$249K Sell
4,029
-1,120
-22% -$73.7K ﹤0.01% 1675
2021
Q2
$438K Buy
5,149
+543
+12% +$49.5K ﹤0.01% 1620
2021
Q1
$364K Buy
4,606
+1,359
+42% +$88.2K ﹤0.01% 1677
2020
Q4
$189K Buy
3,247
+888
+38% +$41.8K ﹤0.01% 1861
2020
Q3
$80K Buy
2,359
+143
+6% +$5.42K ﹤0.01% 1547
2020
Q2
$102K Buy
2,216
+736
+50% +$20.5K ﹤0.01% 1567
2020
Q1
$23K Sell
1,480
-1,166
-44% -$27.8K ﹤0.01% 1134
2019
Q4
$72K Buy
+2,646
New +$70.8K ﹤0.01% 1727
2016
Q4
Sell
-2,098
Closed -$58K 1742
2016
Q3
$58K Sell
2,098
-378
-15% -$10.6K ﹤0.01% 1437
2016
Q2
$61K Sell
2,476
-156
-6% -$5.7K ﹤0.01% 1545
2016
Q1
$98K Sell
2,632
-266
-9% -$10K ﹤0.01% 1522
2015
Q4
$206K Buy
+2,898
New +$197K ﹤0.01% 1527

Other funds holding AFMD

ProShare Advisors's AFMD Position: Q2 2023 in Review

ProShare Advisors sold out of Affimed (AFMD) in Q2 2023, closing a stake of 2,709 shares — an estimated $20.2K sold.

ProShare Advisors first reported a position in AFMD in Q4 2015 and held it in 18 quarters. The position peaked at $438K in Q2 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • ProShare Advisors reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • ProShare Advisors sold 2,709 Affimed shares in Q2 2023, an estimated $20.2K.
  • ProShare Advisors first reported a position in Affimed in Q4 2015 and held it in 18 quarters.
  • ProShare Advisors's Affimed position peaked at $438K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.